TUMOR MARKER SCCA IN THE MONITORING OF TREATMENT OF CERVICAL CANCER
There were analyzed results of primary level of SCCA in 120 patients with cervical cancer patients at different stages of the disease. There were revealed, that with tumor progression the level of SCCA was increased. We’ve defined the direct correlation between the level of SCCA and presence of tumor involvement of local lymphatic nodes, which were confirmed after surgery. The detection of expression level of SCCA is reasonable to make a prognosis for patients and early relapse detection. The primary high level of SCCA correlates to high relapse-rate at follow-up, especially at advanced stages. Due to this fact patients should receive complex antiblastome treatment and stay in proper follow-up.